OK…so a bit of a lazy post…yes however, i found this clip to be both funny and relevant. You be the judge…

• 188http://clsdf.com/2007/06/how-not-to-use-ppt/How+Not+To+Use+.ppt%212007-06-25+02%3A21%3A00admin

You can hear the champagne corks popping from Westminster, CO to Foster City, CA as the FDA late Friday approved Gilead’s (Myogen) Letairis® (ambrisentan) for the treatment of pulmonary arterial hypertension (PAH). There are up to an estimated 90,000 people in the US suffering from PAH, a disease where blood pressure is raised due [...]

• 187http://clsdf.com/2007/06/fda-approval-for-letairis-ambrisentan/FDA+Approval+for+Letairis+%28Ambrisentan%29%21%21%212007-06-19+17%3A51%3A00admin

I would like to bring to your attention the Center for Women’s Health Research at the University of Colorado at Denver and Health Sciences Center. CWHR is committed to improving women’s health by performing vital original research, attracting and training new scientists to the study of women’s health, and providing education to women, healthcare providers, [...]

• 186http://clsdf.com/2007/06/clsdf-to-support-cwhr-you-can-help/CLSDF+to+Support+CWHR%3A+You+Can+Help%212007-06-16+03%3A29%3A00admin

ARCA Discovery, Inc. closed an $18M Series B led by Skyline Ventures and additional new investor InterWest Partners, previous investors Atlas Ventures, Boulder Ventures and the Peierls Foundation also participated in the round.
ARCA is aiming for an NDA submission in 2007 for Bucindolol, a next-generation beta-blocker and vasodilator for heart failure, and plans to seek [...]

• 185http://clsdf.com/2007/06/arca-discovery-18m-series-b/ARCA+Discovery%3A+%2418M+Series+B2007-06-13+23%3A15%3A00admin

I’m always excited when my new edition of Genetic Engineering & Biotechnology News shows up. This is the periodical that keeps me at least efforting to maintain an awareness of the leading edge of discovery, translational medicine, bioprocessing and biobusiness. If you do not receive it yet sign up for your free subscription (here).
How excited [...]

• 184http://clsdf.com/2007/06/i%e2%80%99m-always-excited-when%e2%80%a6/I%E2%80%99m+Always+Excited+When%E2%80%A62007-06-13+23%3A11%3A00admin

Congratulations to ValveXchange for taking top honors in the bioscience category and third place overall in the Bard Center for Entrepreneurship at the University Colorado, Denver and Health Sciences Center 6th Annual Business Plan Competition. Way to go Dr. Vesely!
ValveXchange is a medical device company developing a bioprosthetic heart valve with a percutaneously-exchangeable leaflet set [...]

• 183http://clsdf.com/2007/06/valvexchange-bard-bioscience-winner/ValveXchange%3A+Bard+Bioscience+Winner%212007-06-13+23%3A04%3A00admin

You may have seen the news yesterday on the Archemix and Merck KGaA deal for the use of the SELEX® technology in the oncology field. Well Cambridge and Germany are a long way from Colorado, or are they…
The origins of the Archemix/Merck deal may be traced back to the first floor of Porter Bioscience, home [...]

• 182http://clsdf.com/2007/06/selecting-a-selex%c2%ae-pathway/Selecting+a+SELEX%C2%AE+Pathway2007-06-12+15%3A41%3A00admin

As a part of sprucing up the side-rail I created a new page that contains information on the commercialized and pipeline products in CO. The list is probably about 1% complete as I have started with the public companies first. Please contact me (email) to have your company and product or candidate listed. You can [...]

• 181http://clsdf.com/2007/06/co-commercial-pipeline-products/CO+Commercial+%26amp%3B+Pipeline+Products2007-06-07+14%3A01%3A00admin